Scientists have developed a maternal blood test that can identify thousands of serious genetic conditions in a developing foetus, potentially reducing the need for invasive procedures like amniocentesis. The test analyses fragments of foetal DNA circulating in the mother’s blood and could offer a safer, equally accurate alternative for all pregnancies. It may help detect conditions such as cystic fibrosis and rare disorders like Noonan syndrome, allowing earlier preparation for care.